Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Apr 17, 2017 · 10-K · 107 days after period end · 0001493152-17-003917
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | — | $22.90K |
| Net Income | -$739.83K | -$4.45M | -$222.93K | -$674.45K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Apr 17, 2017 · 107 d after period end
